Skip to content

Toric Orthokeratology - Slowing Eye Elongation

Toric Orthokeratology for Slowing Eye Elongation in Astigmatic Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00978692
Acronym
TO-SEE
Enrollment
80
Registered
2009-09-17
Start date
2008-05-31
Completion date
2012-12-31
Last updated
2016-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Myopia

Keywords

Myopia, Astigmatism, Orthokeratology, Corneal thickness, Corneal curvatures, Corneal biomechanics

Brief summary

The aims of this study are to investigate the effects of ortho-k for astigmatic and myopic reduction and myopic control in children, and the long term effects on corneal curvatures and biomechanics.

Detailed description

Ortho-k has been shown to be effective in correcting low myopia but relatively ineffective for astigmatism, using spherical reverse geometry lens designs. Toric ortho-k lenses have been introduced in recent years but the efficacy for astigmatic reduction and for myopic control in children have not been confirmed. The mechanism of myopic reduction in ortho-k cannot be fully explained by changes to the anterior corneal curvatures. It is therefore possible that other corneal parameters such as posterior corneal curvature and corneal biomechanics may contribute to the mechanism. The current study aims at investigating the efficacy of toric ortho-k lenses for correcting myopic astigmatism and for retarding myopic progression in children compared to children wearing single-vision spectacles. Long term changes to other corneal parameters such as posterior cornea curvatures, topographical corneal thickness, corneal hysteresis, corneal resistance factor, with and without ortho-k lens wear will also be investigated.

Interventions

DEVICEToric Orthokeratology lenses

Children wearing toric orthokeratology at night for correcting astigmatism and myopia will be the study group

Children wearing single-vision spectacles in the daytime for correcting the refractive errors will serve as the control group

Sponsors

Menicon Co., Ltd.
CollaboratorINDUSTRY
The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
Yes

Inclusion criteria

* Myopia (refractive sphere): more than -0.50DS to -5.00DS * Astigmatism: with-the-rule astigmatism more than -1.25DC * Anisometropia: ≤ 1.50D in both refractive sphere * Best corrected monocular visual acuity: equal to or better than 0.10 in logMAR scale in both eyes * Availability for follow-up for at least 2 years

Exclusion criteria

* Strabismus at distance or near * Contraindication for contact lens wear and orthokeratology (e.g. limbus to limbus corneal cylinder and dislocated corneal apex * Prior experience with the use of rigid lenses (including orthokeratology) * Prior experience with myopia control treatment (e.g. refractive therapy or progressive spectacles) * Systemic or ocular conditions which may affect contact lens wear (e.g. allergy and medication) * Systemic or ocular conditions which may affect refractive development (e.g. Down syndrome, ptosis)

Design outcomes

Primary

MeasureTime frame
To determine the eyeball elongation in children wearing ortho-k lensesBefore lens wear, 6, 12,18, 24 months after lens wear

Secondary

MeasureTime frame
To determine the posterior corneal curvatures, topographic corneal thickness, corneal volume, corneal hysteresis and corneal resistance factor in a group of children and compare these parameters with the ortho-k childrenBefore lens wear, 6, 12,18, 24 months after lens wear
To investigative the efficacy of toric orthokeratology for correcting astigmatism and myopiaBefore lens wear, 6, 12,18, 24 months after lens wear

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026